Form 8-K · Current report
News Corp 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000166
Summary
News Corp filed a Form 8-K disclosing its daily buy-back notifications to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to $1 billion in aggregate repurchases of its Class A and Class B common stock. The company reported buying back 65,927 shares for about US$1.84 million on August 3, 2026, and said it has purchased roughly US$402.1 million of Class A and Class B shares under the program to date.
Key points
- News Corp repurchased 65,927 Class A common shares for US$1,837,820.61 on August 3, 2026.
- Cumulative repurchases reported in the notification total 10,222,998 shares for US$260,122,135.49.
- Under the 2025 Repurchase Program, the company says it has purchased approximately US$402,104,108 of Class A and Class B shares to date.
- Prices paid under the program ranged from US$22.20 to US$29.06.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.